Worldwide therapeutic licensing and acquisition deals share 2009-2018 by disease type

In the period 2009-2018, licensing and acquisition deals concerning oncology accounted for 29 percent of all therapeutic company licensing deals. This graph shows the share of total licensing and acquisition deals of therapeutic companies worldwide for the period from 2009 to 2018, by disease type.

在2009年至2018年期间，涉及肿瘤学的许可和收购交易占所有治疗公司许可交易的29%。本图表展示了2009年至2018年全球治疗公司许可和收购交易总量的份额，按疾病类型划分。